Johnson Matthey (OTCMKTS:JMPLY) Cut to Hold at Zacks Research

Johnson Matthey (OTCMKTS:JMPLY) was downgraded by equities research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Thursday,Zacks.com reports.

Several other brokerages have also issued reports on JMPLY. Jefferies Financial Group raised Johnson Matthey to a “strong-buy” rating in a research report on Thursday, October 9th. Citigroup restated a “neutral” rating on shares of Johnson Matthey in a report on Tuesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy”.

Johnson Matthey Price Performance

JMPLY stock opened at $55.95 on Thursday. The company has a quick ratio of 1.01, a current ratio of 1.42 and a debt-to-equity ratio of 0.57. The business has a 50 day moving average of $54.59 and a 200-day moving average of $48.56. Johnson Matthey has a 12-month low of $29.01 and a 12-month high of $58.40.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.